Literature DB >> 11160609

Trimellitic anhydride-induced allergic response in the guinea pig lung involves antibody-dependent and -independent complement system activation.

C P Larsen1, R R Regal, J F Regal.   

Abstract

Trimellitic anhydride (TMA) is one of many low molecular weight compounds known to cause occupational asthma. In our previous studies the TMA-induced allergic response in guinea pigs was attenuated by depletion of complement. Specifically, the leakage of red blood cells and infiltration of inflammatory cells into the lung after TMA challenge was significantly reduced. Thus, we hypothesize that in the presence of specific antibody, TMA activates the complement system and complement activation products play a role in mediating inflammatory cell infiltration into the lung and lung hemorrhage. Guinea pigs were sensitized by intradermal injection of TMA in corn oil. An increase in the complement activation product C3a was detected in bronchoalveolar lavage, but not in plasma, of both sensitized and nonsensitized guinea pigs after intratracheal challenge with TMA conjugated to GPSA (TMA-GPSA). In vitro experiments demonstrated that TMA-GPSA caused complement activation by antibody-dependent as well as antibody-independent pathways. In sensitized animals, TMA-GPSA challenge caused significant increases in eosinophils, neutrophils, and macrophages in lung, along with increases in red blood cells and protein in the airspace. The infiltration of eosinophils was unique in that the magnitude of the GPSA/TMA-GPSA effect was significantly different between nonsensitized and sensitized animals. C3a concentrations in BAL correlated with all measures of cell infiltration in sensitized animals, but not in nonsensitized animals. These data indicate that complement activation in the absence of antibody is not sufficient for the complete allergic response to occur. Both sensitization and the complement system are required for TMA-induced eosinophilia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160609

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Authors:  Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2016-08-30       Impact factor: 4.407

2.  Trimellitic anhydride-induced eosinophilia in a mouse model of occupational asthma.

Authors:  J F Regal; M E Mohrman; D M Sailstad
Journal:  Toxicol Appl Pharmacol       Date:  2001-09-15       Impact factor: 4.219

3.  Trimellitic anhydride-induced cellular infiltration into Guinea pig lung varies with age but not gender.

Authors:  Christen P Larsen; Jean F Regal
Journal:  Int Arch Allergy Immunol       Date:  2002-01       Impact factor: 2.749

4.  Trimellitic anhydride (TMA) dust induces airway obstruction and eosinophilia in non-sensitized guinea pigs.

Authors:  Christen P Larsen; Jean F Regal
Journal:  Toxicology       Date:  2002-09-02       Impact factor: 4.221

5.  Complement activation is critical for placental ischemia-induced hypertension in the rat.

Authors:  Kathryn E Lillegard; Alex C Johnson; Sarah J Lojovich; Ashley J Bauer; Henry C Marsh; Jeffrey S Gilbert; Jean F Regal
Journal:  Mol Immunol       Date:  2013-05-15       Impact factor: 4.407

6.  Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.

Authors:  Jean F Regal; Jenna M Lund; Cameron R Wing; Kate M Root; Luke McCutcheon; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2019-07-18       Impact factor: 4.407

7.  Trimellitic anhydride induces low-grade mast cell degranulation without specific IgE.

Authors:  Kazuhiro Ogi; Tetsuji Takabayashi; Takechiyo Yamada; Masafumi Sakashita; Masafumi Kanno; Norihiko Narita; Shigeharu Fujieda
Journal:  Toxicol Rep       Date:  2016-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.